Generation of Induced-pluripotent Stem Cells Using Fibroblast-like Synoviocytes Isolated from Joints of Rheumatoid Arthritis Patients

Overview

This article describes a protocol for generating human induced-pluripotent stem cells (iPSCs) from fibroblast-like synoviocytes derived from rheumatoid arthritis patients. The method utilizes a lentiviral system without feeder cells, facilitating the study of rheumatoid arthritis pathology.

Key Study Components

Area of Science

• Stem Cell Biology
• Rheumatology
• Cellular Reprogramming

Background

• Induced-pluripotent stem cells (iPSCs) can be derived from various human primary cells.
• Fibroblast-like synoviocytes are key pathological cells in rheumatoid arthritis.
• Understanding iPSC generation from these cells can aid in studying disease mechanisms.
• This research may provide insights into the degeneration of iPSCs using rheumatoid arthritis fibroblast-like synoviocytes (RA-FLSs).

Purpose of Study

• To generate iPSCs from patient-derived fibroblast-like synoviocytes.
• To investigate the pathology of rheumatoid arthritis.
• To develop a protocol that does not require feeder cells.

Methods Used

• Isolation of synovial tissue from rheumatoid arthritis patients.
• Washing tissue with PBS supplemented with antibiotics.
• Utilization of a lentiviral system for reprogramming cells.
• Culture of derived iPSCs for further analysis.

Main Results

• Successful generation of iPSCs from fibroblast-like synoviocytes.
• Demonstration of the feasibility of the protocol without feeder cells.
• Potential for further research into rheumatoid arthritis pathology.
• Contribution to understanding iPSC degeneration using RA-FLSs.

Conclusions

• The protocol provides a reliable method for generating iPSCs from rheumatoid arthritis patients.
• This approach may enhance the study of disease mechanisms and potential therapies.
• Future research can build on these findings to explore iPSC applications in regenerative medicine.

Frequently Asked Questions